Table 1.
Pretreatment Characteristics of All Patients.
| Patient character | WBRT + HA (n = 27) | WBRT (n = 20) | P value |
|---|---|---|---|
| Age | 60.9 ± 7.4 | 63.7 ± 10.3 | 0.28 |
| Gender | 0.32 | ||
| F | 6 (22.2) | 8 (40) | |
| M | 21 (77.8) | 12 (60) | |
| Education | 0.98 | ||
| College/University | 1 (3.7) | 1 (5) | |
| None | 2 (7.4) | 1 (5) | |
| Primary | 17 (63) | 13 (65) | |
| Secondary | 7 (25.9) | 5 (25) | |
| Types of lung cancer | 0.40 | ||
| Adenocarcinoma | 15 (55.6) | 13 (65) | |
| Squamous cell carcinoma | 12 (44.4) | 7 (35) | |
| Metastasis | 0.10 | ||
| Multiple | 19 (70.4) | 10 (50) | |
| Single | 8 (29.6) | 10 (50) | |
| Mean metastasis number | 3.19 ± 3.03 | 4.55 ± 4.98 | 0.25 |
| Metastasis size (mm) | 32.7 ± 14.4 | 28.4 ± 15.5 | 0.33 |
| Other metastasis | 0.24 | ||
| Yes | 14 (51.9) | 14 (70.0) | |
| No | 13 (48.1) | 6 (30.0) | |
| Prognostic score (PS) | 0.72 | ||
| <2 | 22 (81.5) | 15 (75.0) | |
| ≥2 | 5 (18.5) | 5 (25.0) | |
| RPA grade | >0.99 | ||
| <II | 13 (48.1) | 10 (50.0) | |
| ≥II | 14 (51.9) | 10 (50.0) | |
| MMSE base line | 29.2 ± 0.8 | 28.9 ± 1.1 | 0.18 |
| MoCA base line | 28.7 ± 0.8 | 29.0 ± 0.9 | 0.30 |